SCHEMBL20381087

SCHEMBL20381087

CC(C)(C)c1ccc2[nH]c(C(=O)NCCO)cc2c1

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ KDM4E B2RXH2 5/20 0.53
▸ ALDH1A1 P00352 2/20 0.53
▸ AKR1C3 P42330 1/20 0.51
▸ HRH4 Q9H3N8 1/20 0.51
▸ HRH3 Q9Y5N1 1/20 0.51
▸ MAPT P10636 2/20 0.50
▸ PYGL P06737 4/20 0.49
▸ DRD2 P14416 1/20 0.49
▸ DRD3 P35462 1/20 0.49
▸ HTR2C P28335 1/20 0.48
▸ HDAC1 Q13547 2/20 0.47
▸ HDAC2 Q92769 2/20 0.47
▸ NPC1 O15118 1/20 0.47
▸ RAB9A P51151 1/20 0.47
▸ HSD17B10 Q99714 1/20 0.46
▸ CNR1 P21554 1/20 0.46
▸ HDAC3 O15379 1/20 0.46
▸ HDAC4 P56524 1/20 0.46
▸ HDAC7 Q8WUI4 1/20 0.46
▸ HDAC10 Q969S8 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14845695 0.82 HDAC1 (0.66) KDM4EALDH1A1AKR1C3HRH4HRH3
SCHEMBL12826975 0.82 ALOX15 (0.52) KDM4EALDH1A1HRH4PYGLNPC1
SCHEMBL20381129 0.82 TP53 (0.43) KDM4EALDH1A1HRH4HRH3PYGL
SCHEMBL13334403 0.81 KDM4E (0.67) KDM4EMAPTHDAC1HDAC2NPC1
SCHEMBL13334344 0.81 TP53 (0.47) KDM4EALDH1A1HRH4MAPTPYGL
SCHEMBL15099964 0.80 KDM4E (0.79) KDM4EALDH1A1AKR1C3HRH4HRH3
SCHEMBL19085807 0.79 KDM4E (0.53) KDM4EALDH1A1AKR1C3HRH4HRH3
SCHEMBL19085805 0.79 EGFR (0.44) KDM4EALDH1A1MAPTPYGLDRD2
SCHEMBL12846299 0.78 ALOX15 (0.56) KDM4EALDH1A1MAPTPYGLDRD2
SCHEMBL29904432 0.77 KDM4E (0.83) KDM4EALDH1A1AKR1C3DRD2DRD3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10987348-B2 Modulators of ATP-binding cassette transporters VERTEX PHARMACEUTICALS INCORPORATED (US) 2021-04-27 — — US disclosed
US-20190076419-A1 MODULATORS OF ATP-BINDING CASSETTE TRANSPORTERS VERTEX PHARMACEUTICALS INCORPORATED (US) 2019-03-14 — — US disclosed
US-10022352-B2 Modulators of ATP-binding cassette transporters VERTEX PHARMACEUTICALS INCORPORATED (US) 2018-07-17 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10987348-B2 Modulators of ATP-binding cassette transporters CFTR, ABCB1, ABCC2 KDM4E 4235/4885ALDH1A1 1961/4885AKR1C3 989/4885
US-20190076419-A1 MODULATORS OF ATP-BINDING CASSETTE TRANSPORTERS CFTR, ABCB1, ABCC2 KDM4E 4235/4885ALDH1A1 1961/4885AKR1C3 989/4885
US-10022352-B2 Modulators of ATP-binding cassette transporters CFTR, ABCB1, ABCC2 KDM4E 4235/4885ALDH1A1 1961/4885AKR1C3 989/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback